🇺🇸 FDA
Patent

US 8247421

5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

granted A61PA61P1/00A61P1/02

Quick answer

US patent 8247421 (5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
79
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/16, A61P11/06